Investigating a new drug for people who have multi-drug resistant HIV

Investigating a new drug for people who have multi-drug resistant HIV

HELLO – Here at the UW ACTU we are conducting a new study to evaluatean investigational drug for heavily treatment-experienced people who have multi-drug resistant HIV infection. The study drug is BMS-663068 (or fostemsavir), an attachment inhibitor that appears from early studies to be more effective than previous attachment inhibitors. As you know, combination antiretroviral […]